Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model.
about
Regeneration of the lung: Lung stem cells and the development of lung mimicking devicesStrategies for whole lung tissue engineering.Differentiation of mouse induced pluripotent stem cells into alveolar epithelial cells in vitro for use in vivo.CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix.Alveolar epithelial differentiation of human induced pluripotent stem cells in a rotating bioreactor.Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis.Very late antigen-5 facilitates stromal progenitor cell differentiation into myofibroblast.Looking for the elusive lung stem cell niche.Development of Lung Epithelium from Induced Pluripotent Stem Cells.Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.CD166(pos) subpopulation from differentiated human ES and iPS cells support repair of acute lung injury.A review of current and novel therapies for idiopathic pulmonary fibrosisRole of T cells in a gp91phox knockout murine model of acute allergic asthma.Dissecting asthma pathogenesis through study of patterns of cellular traffic indicative of molecular switches operative in inflammation.Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition.Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell.Introduction to stem cells and regenerative medicine.The potential of cell-based therapy in lung diseases.The development of the bioartificial lung.Safely targeting cancer stem cells via selective catenin coactivator antagonism.Mesenchymal stem cells for therapeutic applications in pulmonary medicine.Current status of pluripotent stem cells: moving the first therapies to the clinic.Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease.Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation.Layered double hydroxide nanoparticles promote self-renewal of mouse embryonic stem cells through the PI3K signaling pathway.Therapeutic effect of lung mixed culture-derived epithelial cells on lung fibrosis.CBP/Catenin antagonists: Targeting LSCs' Achilles heel.New treatment directions for IPF: current status of ongoing and upcoming clinical trials.Mesenchymal Stem Cells Promoted Lung Wound Repair through Hox A9 during Endotoxemia-Induced Acute Lung Injury.Inhibition of β-catenin/p300 interaction proximalizes mouse embryonic lung epithelium.Effects of Neuropeptide Y on Stem Cells and Their Potential Applications in Disease Therapy.Protection against hyperoxia-induced lung fibrosis by KGF-induced MSCs mobilization in neonatal rats.Recent advances in lung transplantationCell Therapy in Idiopathic Pulmonary Fibrosis
P2860
Q26750856-3D0BF148-5D8C-4579-A28F-345872F4AFF0Q30413056-DC1F67BA-258F-4C9A-BFD6-B2EC3E4CA3F4Q33689996-EBEDF647-FD8A-459A-8A90-9482523A9947Q33926141-F81AF731-B2B2-4951-8622-32DDA9A00C62Q34038571-B2D4800F-CC16-4A11-8481-1AB9021C796FQ34038613-43B96B7D-E51D-432C-8AC5-C05F2C988E43Q34285405-4DCC6500-A473-4AD4-8A55-F54E75F1FFB7Q34428964-E16057CD-AB37-482A-B2E2-28B762686E35Q35529236-304372CB-39E8-43FF-AD49-778EEB6AB2F5Q35674313-631A99ED-0B55-4332-A630-B7754A7F63D2Q35694549-AAB0217C-FCA1-42EB-9659-13C28194BCADQ36460474-585D34C0-2E45-4F94-95E2-E10D0C48AB03Q36542274-925AACBF-8E1E-42F9-8C5D-E5FED89B353EQ36814775-5F19D4DB-69D5-424E-AA03-5C4BDD3BE63AQ37122082-AFF8BAD1-DCCF-4764-A30E-FF8593379B51Q37413716-8018B2E4-0D81-4362-AE23-FB311DD27C13Q37604825-4C83CA94-05AF-4855-B00D-BE0C55C17A74Q38069041-F72290E0-CDE2-4CF3-BE4C-D2DD79C6FE4AQ38132249-7FFF0962-1A82-4F83-889C-33BF593A3476Q38172446-562B4BFE-01CF-4FA2-8BC3-E4FC7D0F53FDQ38224211-7D16B53C-6A42-40B5-B54E-468142C3FAD0Q38524367-10C8C09C-9EE3-4258-86B4-C231D9D4083FQ38590664-4BEF84D6-0D49-4A43-A356-9949D65CBD06Q38642870-71FE4F92-B76D-4FAD-AA1C-137A7B3108F8Q38786359-EEA03769-FC05-4477-B2C3-E3BF730F4203Q38865503-C56EDA23-C7D9-4121-B2EB-E6FD667FBBC5Q39132988-4F520C09-6088-4EA9-93A5-1FED8A42C71CQ39289235-9320CE46-F078-42C3-87A6-41C0781A5D8FQ39330304-BE693568-EBBC-4433-9FBA-EE505E054BB1Q40228924-322C7B89-C1C2-4899-AC73-218811F1FD06Q42151507-564429EC-8478-4DDE-9C79-6872C1732EAFQ47095240-AF897D80-36C6-4F11-87B5-A7AEE4521FA9Q47847209-A7B84D3A-F92C-4DE6-BBE6-DA62641E0E8BQ58714125-07BE6212-75D5-4B38-AF9C-38EC98FBD21EQ58783975-925CB9E3-1CB8-419A-ABE0-A99FE50F568A
P2860
Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Human embryonic stem cells dif ...... ograft transplant mouse model.
@ast
Human embryonic stem cells dif ...... ograft transplant mouse model.
@en
type
label
Human embryonic stem cells dif ...... ograft transplant mouse model.
@ast
Human embryonic stem cells dif ...... ograft transplant mouse model.
@en
prefLabel
Human embryonic stem cells dif ...... ograft transplant mouse model.
@ast
Human embryonic stem cells dif ...... ograft transplant mouse model.
@en
P2093
P2860
P1433
P1476
Human embryonic stem cells dif ...... ograft transplant mouse model.
@en
P2093
Charles E Murry
Ena Ray Banerjee
Michael Kahn
Thalia Papayannopoulou
William R Henderson
P2860
P304
P356
10.1371/JOURNAL.PONE.0033165
P407
P577
2012-03-28T00:00:00Z